Red Spruce Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $912K | Buy |
1,701
+19
| +1% | +$10.2K | 0.4% | 66 |
|
|
2025
Q1 | $706K | Sell |
1,682
-82
| -5% | -$34.4K | 0.33% | 72 |
|
|
2024
Q4 | $729K | Sell |
1,764
-168
| -9% | -$69.5K | 0.32% | 71 |
|
|
2024
Q3 | $976K | Buy |
1,932
+40
| +2% | +$20.2K | 0.44% | 64 |
|
|
2024
Q2 | $922K | Buy |
1,892
+126
| +7% | +$61.4K | 0.43% | 65 |
|
|
2024
Q1 | $954K | Hold |
1,766
| – | – | 0.44% | 67 |
|
|
2023
Q4 | $980K | Sell |
1,766
-15
| -0.8% | -$8.33K | 0.5% | 64 |
|
|
2023
Q3 | $779K | Sell |
1,781
-17
| -0.9% | -$7.43K | 0.44% | 65 |
|
|
2023
Q2 | $903K | Sell |
1,798
-176
| -9% | -$88.4K | 0.49% | 64 |
|
|
2023
Q1 | $987K | Buy |
1,974
+10
| +0.5% | +$5K | 0.58% | 59 |
|
|
2022
Q4 | $801K | Hold |
1,964
| – | – | 0.51% | 60 |
|
|
2022
Q3 | $640K | Buy |
1,964
+27
| +1% | +$8.8K | 0.45% | 64 |
|
|
2022
Q2 | $679K | Buy |
1,937
+32
| +2% | +$11.2K | 0.45% | 64 |
|
|
2022
Q1 | $1.04M | Buy |
1,905
+133
| +8% | +$72.7K | 0.59% | 55 |
|
|
2021
Q4 | $1.17M | Sell |
1,772
-103
| -5% | -$67.8K | 0.64% | 54 |
|
|
2021
Q3 | $1.17M | Buy |
1,875
+6
| +0.3% | +$3.73K | 0.68% | 55 |
|
|
2021
Q2 | $1.18M | Buy |
1,869
+13
| +0.7% | +$8.21K | 0.7% | 53 |
|
|
2021
Q1 | $908K | Sell |
1,856
-45
| -2% | -$22K | 0.58% | 57 |
|
|
2020
Q4 | $950K | Buy |
1,901
+26
| +1% | +$13K | 0.66% | 54 |
|
|
2020
Q3 | $737K | Hold |
1,875
| – | – | 0.6% | 55 |
|
|
2020
Q2 | $619K | Sell |
1,875
-26
| -1% | -$8.58K | 0.53% | 59 |
|
|
2020
Q1 | $460K | Sell |
1,901
-97
| -5% | -$23.5K | 0.48% | 64 |
|
|
2019
Q4 | $522K | Buy |
+1,998
| New | +$522K | 0.44% | 63 |
|